VJOncology is committed to improving our service to you

ASCO 2019 | Radium-223 in men with bone mCRPC

VJOncology is committed to improving our service to you

Daniel George

Daniel George, MD, of the Duke University Cancer Center, Durham, NC, discusses the use of Radium-223 in the treatment of bone metastatic castrate resistant prostate cancer at the American Society of Oncology (ASCO) 2019 Annual Meeting, held in Chicago, IL.

Share this video  

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter